Atlas FDA

Dexcom G5 Mobile Continuous Glucose Monitoring System

FDA premarket approval P120005/S050 · decided 2017-03-08

Approval details

PMA number
P120005
Supplement
S050
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Dexcom G5 Mobile Continuous Glucose Monitoring System
Generic name
Sensor, glucose, invasive, non-adjunctive
Applicant
Dexcom, Inc.
Date received
2016-06-22
Decision date
2017-03-08
Days to decision
259 days
Decision code
APPR
Product code
PQF
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
Approval for a new touchscreen receiver component for the G5 Mobile Continuous Glucose Monitoring (CGM) System

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23